MHRA mulls reclassifying diclofenac as a POM
Clinical The NSAID diclofenac could be reclassified as a prescription-only-medicine (POM) because of concerns over the high cardiovascular risk associated with the painkiller.
The NSAID diclofenac could be reclassified as a prescription-only medicine (POM) because of concerns over the cardiovascular risk associated with the painkiller.
The MHRA is